# Follicle Stimulating Hormone (FSH) to Improve Testicular Development in Men With Hypogonadism

> **NCT00064987** · PHASE2 · TERMINATED · sponsor: **Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)** · enrollment: 19 (actual)

## Conditions studied

- Hypogonadism
- Kallmann Syndrome

## Interventions

- **PROCEDURE:** Testicular biopsy
- **DRUG:** gonadotropin releasing hormone (GnRH)
- **DRUG:** follicle stimulating hormone (FSH)

## Key facts

- **NCT ID:** NCT00064987
- **Lead sponsor:** Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2001-04
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Recruitment was at a standstill. We are currently preparing our results for publication.
- **Last updated:** 2017-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00064987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00064987, "Follicle Stimulating Hormone (FSH) to Improve Testicular Development in Men With Hypogonadism". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00064987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*